Pediatric Heart Failure Pharmacotherapy: Transformative Insights for the Future [PDF]
Reviews in Cardiovascular MedicineThis review aims to summarize the status and future directions of pediatric heart failure (HF) pharmacotherapy. Notably, managing HF in children presents unique challenges due to heterogeneous etiologies and a longstanding paucity of pediatric-specific ...
Bibhuti B Das
doaj +2 more sources
Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction. [PDF]
PLoS ONE, 2016 Biomarker discovery and new insights into the pathophysiology of heart failure with reduced ejection fraction (HFrEF) may emerge from recent advances in high-throughput urinary proteomics.
Kasper Rossing +10 more
doaj +11 more sources
Comparison of sarcopenia prevalence and prognostic features between HFrEF and HFpEF: a systematic review and meta-analysis [PDF]
Frontiers in Cardiovascular MedicineBackgroundSarcopenia is closely associated with heart failure (HF); however, no prior meta-analysis has specifically addressed its relation with different ejection fraction phenotypes. This study investigated the prevalence of sarcopenia in patients with
Weizhu Xiong +5 more
doaj +2 more sources
Biomarker profiles of acute heart failure patients with a mid-range ejection fraction [PDF]
, 2017 OBJECTIVES: In this study, the authors used biomarker profiles to characterize differences between patients with acute heart failure with a midrange ejection fraction (HFmrEF) and compare them with patients with a reduced (heart failure with a ...
Bloomfield, Daniel M +16 more
core +20 more sources
Chest CT-based analysis of radiomic and volumetric differences in epicardial adipose tissue in HFrEF patients with and without AF [PDF]
BMC Cardiovascular DisordersAims Epicardial adipose tissue (EAT) has been implicated in atrial fibrillation (AF). While increased EAT volume (EATV) and EATV index (EATVI) are associated with AF, decreased values have been observed in heart failure with reduced ejection fraction ...
Xiu-ying Song +7 more
doaj +2 more sources
Contemporary management of heart failure patients with reduced ejection fraction: the role of implantable devices and catheter ablation [PDF]
Reviews in Cardiovascular Medicine, 2021 Heart failure (HF) is a complex clinical syndrome characterised by significant morbidity and mortality worldwide. Evidence-based therapies for the management of HF include several well-established neurohormonal antagonists and antiarrhythmic drug ...
Catrin Sohrabi +6 more
doaj +1 more source
Autonomic cardiovascular reflex control of hemodynamics during exercise in heart failure with reduced ejection fraction and the effects of exercise training [PDF]
Reviews in Cardiovascular Medicine, 2022 Heart failure with reduced ejection fraction is associated with increased exercise intolerance, morbidity, and mortality. Importantly, exercise intolerance in heart failure with reduced ejection fraction is a key factor limiting patient quality of ...
Natasha G. Boyes +3 more
doaj +1 more source
Global Heart, 2023 Background: The rates of guideline-directed medical therapy (GDMT) prescription for heart failure with reduced ejection fraction (HFrEF) in Asia remain sub-optimal.
Aishwarya Vijay +11 more
doaj +1 more source
Medical Journal of Babylon, 2022 Background and Objective: Heart failure is a major public health problem with 64.3 million people affected all over the world, and it is an important cause for hospital admission and mortality.
Goran Adnan Rahman +1 more
doaj +1 more source
Global Heart, 2023 There appears to be an epidemiological transition in the etiology of heart failure in sub-Saharan Africa (SSA) in parallel with a steady increase in risk factors for coronary artery disease (CAD).
Redemptar Kimeu +2 more
doaj +1 more source